Search

Your search keyword '"Shoaie, Saeed"' showing total 269 results

Search Constraints

Start Over You searched for: Author "Shoaie, Saeed" Remove constraint Author: "Shoaie, Saeed"
269 results on '"Shoaie, Saeed"'

Search Results

1. Detection and consistency of mucosal fluid T lymphocyte phenotypes and their relationship with blood, age and gender

4. Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

6. Publisher Correction: MEMOTE for standardized genome-scale metabolic model testing

8. OS-070 Faecal microbiota transplantation in patients with cirrhosis, reduces antimicrobial resistance and enteric pathogen carriage, and enhances intestinal barrier function, associated with bacteriophage remodelling

9. WED-078 Systemic albumin administration improves the gut microbiome and intestinal permeability in animal models of cirrhosis and ACLF

10. FRI-039 Terlipressin therapy is associated with increased risk of colonization with multidrug-resistant bacteria in patients with decompensated cirrhosis

11. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis

15. Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach.

18. Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases.

21. Retraction notice to “Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases” [Life Sci. 314 (2023) 121325]

23. P56 The role of albumin in modulating the microbiome composition: studies in analbuminaemic and wild type cirrhosis rats

24. Impact of Yaq-001, a non-absorbable, engineered carbon bead of controlled porosity in rodent models of cirrhosis and acute on chronic liver failure

25. Pathogenic entero- and salivatypes harbour changes in microbiome virulence and antimicrobial resistance genes with increasing chronic liver disease severity

26. Yaq-001, a non-absorbable, engineered carbon beads of controlled porosity impacts on gut dysbiosis, gut permeability, organ function and reduces mortality in rodent models of cirrhosis and ACLF

27. Faecal microbiota transplant restores gut barrier function and augments ammonia metabolism in patients with advanced cirrhosis: a randomised single-blind placebo-controlled trial

28. Global compositional and functional states of the human gut microbiome in health and disease

29. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

35. Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

36. Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase

38. Fungal infection drives metabolic reprogramming in epithelial cells via aerobic glycolysis and an alternative TCA cycle shunt

39. Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomised, Double-Blinded, Placebo-Controlled Phase-II Trial

40. RETRACTED: Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

42. Combined Metabolic Activators Improves Cognitive Functions in Alzheimer’s Disease Patients

43. In-depth shotgun metagenomic analysis of the oral and gut microbiome identifies striking overlap in microbial community structure, virulence factors and antimicrobial resistance genes based on stage and severity of cirrhosis

46. Multi-omics analyses reveal multimodal Fusobacterium DNA damage perturbations in colorectal cancer

48. Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach

49. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma

50. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma

Catalog

Books, media, physical & digital resources